Showing 281 - 300 results of 650 for search '"Rhode Island Hospital"', query time: 0.48s Refine Results
  1. 281
  2. 282
  3. 283

    Murine Leukemia-Derived Extracellular Vesicles Elicit Antitumor Immune Response by Pando A, Fast L, Dubielecka PM, Chorzalska A, Wen S, Reagan J

    Published 2021-05-01
    “…Alejandro Pando, Loren Fast, Patrycja M Dubielecka, Anna Chorzalska, Sicheng Wen, John Reagan Division of Hematology/Oncology, Department of Medicine, Rhode Island Hospital and the Warren Alpert School of Medicine at Brown University, Providence, RI, USACorrespondence: Loren FastDivision of Hematology/Oncology, Department of Medicine, Rhode Island Hospital and the Warren Alpert School of Medicine at Brown University, 31 S Killingly Road, Foster, RI, 02825, USATel +1 401 533-8658Email Loren_Fast@brown.eduBackground: Extracellular vesicles (EVs) are heterogeneous lipid bilayer particles secreted by cells. …”
    Get full text
    Article
  4. 284
  5. 285
  6. 286
  7. 287

    Advances in Immunotherapy for the Treatment of Cutaneous T-Cell Lymphoma by Pelcovits A, Ollila TA, Olszewski AJ

    Published 2023-09-01
    “…Ari Pelcovits,1,2 Thomas A Ollila,1,2 Adam J Olszewski1,2 1Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA; 2Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI, USACorrespondence: Adam J Olszewski, Department of Medicine, Alpert Medical School of Brown University, Rhode Island Hospital, George Building, Ste 310, 593 Eddy St, Providence, RI, 02903, USA, Tel +1-401-444-2269, Fax +1-401-444-4184, Email adam_olszewski@brown.eduAbstract: Cutaneous T-Cell Lymphoma (CTCL) is a heterogenous disease that consists of distinct clinicopathologic entities and presentations requiring a unique and expert approach to management. …”
    Get full text
    Article
  8. 288
  9. 289
  10. 290
  11. 291
  12. 292
  13. 293
  14. 294
  15. 295
  16. 296
  17. 297
  18. 298
  19. 299
  20. 300